NLRC5 potentiates anti-tumor CD8+ T cells responses by activating interferon-β in endometrial cancer

Jing Zhang,Bao Guo,Jia-Hua Chen,Xiao-Jing Liu,Jun-Hui Zhang,Hai-Qing Zhu,Wen-Yan Wang,Zhen-Hai Tang,Bing Wei,Yun-Xia Cao,Lei Zhan
DOI: https://doi.org/10.1016/j.tranon.2023.101742
IF: 4.803
2023-01-01
Translational Oncology
Abstract:•NLRC5 potentiates antitumor responses of CD8+ T cells against EC.•IFN-β promotes immunosurveillance of EC by activating CD8+ T cells.•NLRC5 potentiates antitumor responses of CD8+ T cells to EC by activating IFN-β.
What problem does this paper attempt to address?